Bcr-Abl
Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).
- B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- B1011 Bafetinib (INNO-406)2 Citation中文名: 巴氟替尼Summary: Bcr-Abl/Lyn酪氨酸激酶抑制剂
- A8812 PD173955Target: Bcr-Abl|SrcSummary: Src/Abl激酶双重抑制剂
- A8607 PPY ATarget: Abl kinasesSummary: Abl激酶抑制剂
- A8606 PD 180970Summary: P210 bcr/abl酪氨酸激酶抑制剂
- A8605 1-Naphthyl PP1Summary: Src家族激酶抑制剂
- A8604 GNF 5Target: Bcr-AblSummary: Bcr-Abl抑制剂
- A8603 GNF 2Summary: Bcr-Abl抑制剂
- A8602 AdaphostinSummary: P210 bcr/abl酪氨酸激酶抑制剂